{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:37:04Z","timestamp":1791916624322,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"17","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The aim of this study is to describe the demographic, presenting features and associated risk factors of ocular surface squamous neoplasia (OSSN) at a tertiary eye hospital in Johannesburg, South Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An interventional prospective study of patients presenting with conjunctival masses was conducted. An electronic questionnaire was completed to document demographic data, presenting history, and associated risk factors. A slit lamp examination and photos were used to document and describe the clinical features at presentation. Cases (OSSN) and controls (benign lesions) were determined by histology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were 130 cases and 45 controls. Median age was 44 years (IQR: 35\u201351) with an equal gender distribution in cases. The prevalence of HIV in cases was 74% and was strongly associated with OSSN (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Vascularisation, leukoplakia and pigmentation were clinical features that distinguished cases from controls. A fibrovascular morphology was strongly associated with a benign histology (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), whereas leukoplakic and gelatinous morphologies were associated with OSSN. Conjunctival intra-epithelial neoplasia made up 82% of cases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study describes a sample of OSSN that is young and has no gender predisposition. The majority of cases presented with CIN lesions, rather than SCC reported in other African countries. HIV was the most significant risk factor in this study population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-023-02565-1","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T12:04:45Z","timestamp":1685534685000},"page":"3602-3608","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Demographics, clinical presentation and risk factors of ocular surface squamous neoplasia at a tertiary hospital, South Africa"],"prefix":"10.1038","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4375-2224","authenticated-orcid":false,"given":"Roland","family":"H\u04e7llhumer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Michelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4479-8638","authenticated-orcid":false,"given":"Susan","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"2565_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0039-6257(05)80054-2","volume":"39","author":"GA Lee","year":"1995","unstructured":"Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39:429\u201350.","journal-title":"Surv Ophthalmol"},{"key":"2565_CR2","first-page":"109","volume":"6","author":"CL Shields","year":"2017","unstructured":"Shields CL, Chien JL, Surakiatchanukul T, Sioufi K, Lally SE, Shields JA. Conjunctival tumors: review of clinical features, risks, biomarkers, and outcomes\u2014The 2017 J. Donald M. Gass Lecture. Asia Pac J Ophthalmol. 2017;6:109\u201320.","journal-title":"Asia Pac J Ophthalmol"},{"key":"2565_CR3","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/tmi.12203","volume":"18","author":"S Gichuhi","year":"2013","unstructured":"Gichuhi S, Sagoo MS, Weiss HA, Burton MJ. Epidemiology of ocular surface squamous neoplasia in Africa. Trop Med Int Health. 2013;18:1424\u201343.","journal-title":"Trop Med Int Health"},{"key":"2565_CR4","doi-asserted-by":"crossref","unstructured":"Hollhumer R, Williams S, Michelow P. Ocular surface squamous neoplasia: population demographics, pathogenesis and risk factors. Afr Vis Eye Health. 2020;79. http:\/\/www.avehjournal.org\/index.php\/AVEH\/article\/view\/553.","DOI":"10.4102\/aveh.v79i1.553"},{"key":"2565_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/00003226-200310000-00015","volume":"22","author":"S Basti","year":"2003","unstructured":"Basti S, Macsai MS. Ocular surface squamous neoplasia: a review. Cornea. 2003;22:687\u2013704.","journal-title":"Cornea."},{"key":"2565_CR6","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1001\/archopht.1997.01100150810025","volume":"115","author":"JA Shields","year":"1997","unstructured":"Shields JA. Surgical management of conjunctival tumors: the 1994 Lynn B. McMahan Lecture. Arch Ophthalmol. 1997;115:808.","journal-title":"Arch Ophthalmol"},{"key":"2565_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.exer.2014.10.015","volume":"129","author":"S Gichuhi","year":"2014","unstructured":"Gichuhi S, Ohnuma S, Sagoo MS, Burton MJ. Pathophysiology of ocular surface squamous neoplasia. Exp Eye Res. 2014;129:172\u201382.","journal-title":"Exp Eye Res"},{"key":"2565_CR8","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1111\/tmi.12792","volume":"21","author":"S Gichuhi","year":"2016","unstructured":"Gichuhi S, Macharia E, Kabiru J, Zindamoyen AM, Rono H, Ollando E, et al. Risk factors for ocular surface squamous neoplasia in Kenya: a case-control study. Trop Med Int Health. 2016;21:1522\u201330.","journal-title":"Trop Med Int Health"},{"key":"2565_CR9","first-page":"27","volume":"21","author":"C Napora","year":"1990","unstructured":"Napora C, Cohen EJ, Genvert GI, Presson AC, Arentsen JJ, Eagle RC, et al. Factors associated with conjunctival intraepithelial neoplasia: a case control study. Ophthalmic Surg. 1990;21:27\u201330.","journal-title":"Ophthalmic Surg"},{"key":"2565_CR10","unstructured":"Anon. GNI per capita, Atlas method (current US$) | Data. 2022. https:\/\/data.worldbank.org\/indicator\/NY.GNP.PCAP.CD."},{"key":"2565_CR11","doi-asserted-by":"crossref","unstructured":"Fasina O. Ocular surface squamous neoplasia at a tertiary eye facility, Southwestern Nigeria: a 10-year review. Int Ophthalmol. 2021. https:\/\/link.springer.com\/10.1007\/s10792-021-01894-y.","DOI":"10.1007\/s10792-021-01894-y"},{"key":"2565_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000511610","volume":"7","author":"P Julius","year":"2021","unstructured":"Julius P, Siyumbwa SN, Moonga P, Maate F, Kaile T, Kang G, et al. Clinical and pathologic presentation of primary ocular surface tumors among Zambians. Ocul Oncol Pathol. 2021;7:108\u201320.","journal-title":"Ocul Oncol Pathol"},{"key":"2565_CR13","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.ophtha.2015.04.027","volume":"122","author":"S Kamal","year":"2015","unstructured":"Kamal S, Kaliki S, Mishra DK, Batra J, Naik MN. Ocular surface squamous neoplasia in 200 patients. Ophthalmology. 2015;122:1688\u201394.","journal-title":"Ophthalmology."},{"key":"2565_CR14","doi-asserted-by":"crossref","unstructured":"Kaliki S, Vempuluru VS, Ghose N, Gunda S, Vithalani NM, Sultana S, et al. Ocular surface squamous neoplasia in India: a study of 438 patients. Int Ophthalmol. 2022. https:\/\/link.springer.com\/10.1007\/s10792-021-02189-y.","DOI":"10.1007\/s10792-021-02189-y"},{"key":"2565_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-022-02340-y","volume":"22","author":"N Tananuvat","year":"2022","unstructured":"Tananuvat N, Niparugs M, Wiwatwongwana D, Lertprasertsuk N, Mahanupap P. Ocular surface squamous neoplasia in Northern Thailand: a 16-year review. BMC Ophthalmol. 2022;22:121.","journal-title":"BMC Ophthalmol"},{"key":"2565_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/ICL.0b013e318223394e","volume":"37","author":"M Coroneo","year":"2011","unstructured":"Coroneo M. Ultraviolet radiation and the anterior eyei. Eye Contact Lens Sci Clin Pr. 2011;37:214\u201324.","journal-title":"Eye Contact Lens Sci Clin Pr"},{"key":"2565_CR17","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1001\/jamaophthalmol.2015.3335","volume":"133","author":"S Gichuhi","year":"2015","unstructured":"Gichuhi S, Macharia E, Kabiru J, Zindamoyen AM, Rono H, Ollando E, et al. Clinical presentation of ocular surface squamous neoplasia in Kenya. JAMA Ophthalmol. 2015;133:1305.","journal-title":"JAMA Ophthalmol"},{"key":"2565_CR18","doi-asserted-by":"crossref","unstructured":"Bowen RC, Soto H, Raval V, Bellerive C, Yeaney G, Singh AD. Ocular surface squamous neoplasia: outcomes following primary excision with 2 mm margin and cryotherapy. Eye. 2021. http:\/\/www.nature.com\/articles\/s41433-020-01353-5.","DOI":"10.1038\/s41433-020-01353-5"},{"key":"2565_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0039-6257(98)00020-4","volume":"43","author":"AD Singh","year":"1998","unstructured":"Singh AD, Campos OE, Rhatigan RM, Schulman JA, Misra RP. Conjunctival melanoma in the Black population. Surv Ophthalmol. 1998;43:127\u201333.","journal-title":"Surv Ophthalmol"},{"key":"2565_CR20","doi-asserted-by":"crossref","unstructured":"Suleiman DE, Liman AA, Waziri GD, Iliyasu Y, Ahmed SA. Clinicopathological characteristics of ocular surface squamous neoplasia: a 10-year review form a referral tertiary centre in Nigeria. Int Ophthalmol. 2022. https:\/\/link.springer.com\/10.1007\/s10792-022-02411-5.","DOI":"10.21203\/rs.3.rs-1171664\/v1"},{"key":"2565_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S2221-1691(11)60015-4","volume":"1","author":"AI Osahon","year":"2011","unstructured":"Osahon AI, Ukponmwan CU, Uhunmwangho OM. Prevalence of HIV seropositivity among patients with squamous cell carcinoma of the conjunctiva. Asian Pac J Trop Biomed. 2011;1:150\u20133.","journal-title":"Asian Pac J Trop Biomed"},{"key":"2565_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.7196\/SAMJ.8254","volume":"105","author":"KT Steele","year":"2015","unstructured":"Steele KT, Steenhoff AP, Bisson GP, Nkomazana O. Ocular surface squamous neoplasia among HIV-infected patients in Botswana. S Afr Med J. 2015;105:379.","journal-title":"S Afr Med J"},{"key":"2565_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/archophthalmol.2008.531","volume":"127","author":"LW Hirst","year":"2009","unstructured":"Hirst LW, Axelson R, Schwab I. Pterygium and associated ocular surface squamous neoplasia. Arch Ophthalmol. 2009;127:31.","journal-title":"Arch Ophthalmol"},{"key":"2565_CR24","doi-asserted-by":"crossref","unstructured":"Spitzer MS, Batumba NH, Chirambo T, Bartz-Schmidt K, Kayange P, Kalua K, et al. Ocular surface squamous neoplasia as the first apparent manifestation of HIV infection in Malawi. Clin Exp Ophthalmol. 2008. http:\/\/doi.wiley.com\/10.1111\/j.1442-9071.2008.01794.x.","DOI":"10.1111\/j.1442-9071.2008.01794.x"},{"key":"2565_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/sj.bjc.6600451","volume":"87","author":"R Newton","year":"2002","unstructured":"Uganda Kaposi\u2019s Sarcoma Study Group, Newton R, Ziegler J, Ateenyi-Agaba C, Bousarghin L, Casabonne D, et al. The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer. 2002;87:301\u20138.","journal-title":"Br J Cancer"},{"key":"2565_CR26","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/sj.eye.6702043","volume":"20","author":"KM Waddell","year":"2006","unstructured":"Waddell KM, Downing RG, Lucas SB, Newton R. Corneo-conjunctival carcinoma in Uganda. Eye. 2006;20:893\u20139.","journal-title":"Eye."},{"key":"2565_CR27","doi-asserted-by":"crossref","unstructured":"Shields CL, Paulose SA, Yaghy A, Dalvin LA, Constantinescu AB, Lally SE, et al. Ocular surface squamous neoplasia managed with primary interferon a2b: a comparative analysis of 212 tumors in smokers versus nonsmokers. Cornea. 2021;40:1387\u201394.","DOI":"10.1097\/ICO.0000000000002615"},{"key":"2565_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jcrs.2017.03.002","volume":"43","author":"JA Hovanesian","year":"2017","unstructured":"Hovanesian JA, Starr CE, Vroman DT, Mah FS, Gomes JAP, Farid M, et al. Surgical techniques and adjuvants for the management of primary and recurrent pterygia. J Cataract Refract Surg. 2017;43:405\u201319.","journal-title":"J Cataract Refract Surg"},{"key":"2565_CR29","doi-asserted-by":"crossref","unstructured":"Gichuhi S, Kabiru J, M\u2019bongo Zindamoyen A, Rono H, Ollando E, Wachira J, et al. Delay along the care-seeking journey of patients with ocular surface squamous neoplasia in Kenya. BMC Health Serv Res. 2017;17. http:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-017-2428-4.","DOI":"10.1186\/s12913-017-2428-4"},{"key":"2565_CR30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.21149\/12796","volume":"64","author":"P De La Parra-Colin","year":"2022","unstructured":"De La Parra-Colin P, Pichardo-Bahena R, M\u00e9ndez-Mart\u00ednez R, Garc\u00eda-Carranc\u00e1 A, Barrientos-Gutierrez T, Santamar\u00eda-Olmedo M, et al. Association of high-risk human papillomavirus with ocular surface squamous neoplasia: a case-control study in Mexico. Salud P\u00fablica M\u00e9x. 2022;64:209\u201317.","journal-title":"Salud P\u00fablica M\u00e9x"},{"key":"2565_CR31","unstructured":"Hossain RR, McKelvie J. Ocular surface squamous neoplasia in New Zealand: a ten-year review of incidence in the Waikato region. Eye. 2021. http:\/\/www.nature.com\/articles\/s41433-021-01662-3."},{"key":"2565_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ophtha.2011.08.005","volume":"119","author":"YA Yousef","year":"2012","unstructured":"Yousef YA, Finger PT. Squamous carcinoma and dysplasia of the conjunctiva and cornea. Ophthalmology. 2012;119:233\u201340.","journal-title":"Ophthalmology."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02565-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02565-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02565-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T11:09:20Z","timestamp":1700651360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02565-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":32,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2565"],"URL":"https:\/\/doi.org\/10.1038\/s41433-023-02565-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2270584\/v1","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]},"assertion":[{"value":"14 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}